Improvements of transplant graft survival possible with anti-rejection protocol
Transplant researchers at the University of Pittsburgh’s Thomas E. Starzl Transplantation Institute have revealed that a novel immunosuppression minimization protocol could possibly have the capability of enhancing intestinal transplant graft survival and minimizing rejection and infection rates.
The protocol has justified its worth by minimizing the quantity of anti-rejection drugs to help patients [...]
September 17, 2010 | Posted in Steroids Blog | Read More »
